Loading...

SOHO 2026 Annual Meeting

This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.

SOHO 2026 Annual Meeting

September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas

Home Posters by Code Posters by Title Authors Affiliations Topics Sessions Videos Audios Previous meetings

Posters by Title

Type your Poster Title, then hit apply

Showing 1,267 results.

Thumbnail for Long-Term Hematologic Control and Safety in Patients With Paroxysmal Nocturnal Hemoglobinuria Treated With Iptacopan: 6-Year Follow-Up From Phase 2 Studies and Roll-Over Extension Program

MDS - 1167

Long-Term Hematologic Control and Safety in Patients With Paroxysmal Nocturnal Hemoglobinuria Treated With Iptacopan: 6-Year Follow-Up From Phase 2 Studies and Roll-Over Extension Program

Nick Kuypers

Poster Presenter: Nick Kuypers

Thumbnail for Long-Term Mortality Trends and Disparities in Chronic Myeloid Leukemia Among Older Adults in the United States: A 1999-2024 CDC WONDER Analysis

CML - 1331

Long-Term Mortality Trends and Disparities in Chronic Myeloid Leukemia Among Older Adults in the United States: A 1999-2024 CDC WONDER Analysis

Adeel Khan

Poster Presenter: Adeel Khan

Previous 1...69 70 71 72 73 74 75...141 Next

Copyright © 2015-2026, ePostersLive® SciGen is a registered trademark of SciGen Technologies S.A. Patent pending.

$Thumbnail for Long-Term Outcomes of Epcoritamab in Relapsed or Refractory Large B-Cell Lymphoma: A Systematic Review of Efficacy, Survival, Minimal Residual Disease, and Safety$

ABCL - 1004

Long-Term Outcomes of Epcoritamab in Relapsed or Refractory Large B-Cell Lymphoma: A Systematic Review of Efficacy, Survival, Minimal Residual Disease, and Safety

Sai Harsha Yendluri

Poster Presenter: Sai Harsha Yendluri

Thumbnail for Long-Term Risk of Clonal Evolution and Infectious Outcomes With Eltrombopag Plus Immunosuppressive Therapy in Idiopathic Aplastic Anemia: A Propensity-Matched Real-World Analysis

MDS - 1661

Long-Term Risk of Clonal Evolution and Infectious Outcomes With Eltrombopag Plus Immunosuppressive Therapy in Idiopathic Aplastic Anemia: A Propensity-Matched Real-World Analysis

Uchenna Amaechi

Poster Presenter: Uchenna Amaechi

Thumbnail for Long-Term Safety With Iptacopan Treatment in Patients With Paroxysmal Nocturnal Hemoglobinuria: Pooled Analysis of Data From Phase 2 and 3 Studies and the Roll-Over Extension Program

MDS - 1159

Long-Term Safety With Iptacopan Treatment in Patients With Paroxysmal Nocturnal Hemoglobinuria: Pooled Analysis of Data From Phase 2 and 3 Studies and the Roll-Over Extension Program

Silvia Sanz, Nick Kuypers

Poster Presenter: Nick Kuypers

Thumbnail for Longer Survival With Tagraxofusp (TAG) vs Venetoclax (VEN) in Patients With Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN): Results of a Real-World Analysis

AML - 610

Longer Survival With Tagraxofusp (TAG) vs Venetoclax (VEN) in Patients With Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN): Results of a Real-World Analysis

Guru Subramanian Guru Murthy

Poster Presenter: Guru Subramanian Guru Murthy

Thumbnail for Low-Cost Peripheral Smear Screening for Early Detection of Hematological Malignancies in Tribal Regions of Maharashtra, India: A Prospective Rural Outreach Study

AML - 500

Low-Cost Peripheral Smear Screening for Early Detection of Hematological Malignancies in Tribal Regions of Maharashtra, India: A Prospective Rural Outreach Study

Maitri Gada

Poster Presenter: Maitri Gada

Thumbnail for Low-Dose Nivolumab Combined With AVD Chemotherapy for Advanced Hodgkin Lymphoma: Interim Results of a Phase 2 Trial

HL - 155

Low-Dose Nivolumab Combined With AVD Chemotherapy for Advanced Hodgkin Lymphoma: Interim Results of a Phase 2 Trial

Mobil Akhmedov

Poster Presenter: Mobil Akhmedov

Thumbnail for Lower Neighborhood Income Independently Predicts Reduced Inpatient Chemotherapy Utilization in Acute Myeloid Leukemia: A National Inpatient Sample Analysis, 2017-2022

AML - 701

Lower Neighborhood Income Independently Predicts Reduced Inpatient Chemotherapy Utilization in Acute Myeloid Leukemia: A National Inpatient Sample Analysis, 2017-2022

Preetham Ezhilarasu

Poster Presenter: Preetham Ezhilarasu

ePosters in

Topics Sessions

Acute Lymphoblastic Leukemia (ALL)(71)Acute Myeloid Leukemia (AML)(230)Aggressive B-Cell Lymphoma (ABCL)(114)Cellular Therapy (CT)(128)Chronic Lymphocytic Leukemia (CLL)(110)Chronic Myeloid Leukemia (CML)(55)Hodgkin Lymphoma (HL)(54)Indolent B-Cell Lymphoma (IBCL)(47)Mantle Cell Lymphoma (MCL)(23)Multiple Myeloma (MM)(234)

Previous 1 2 Next

Sponsors

1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors

ePostersLive by SciGen Technologies S.A. All rights reserved.